Clinical Trials Logo

Clinical Trial Summary

There will be two populations in this study: control group, and intervention group. These groups will undergo propensity matching to account for confounders and minimize selection bias. 120 patients will be enrolled, 60 to each population. The objective of this study is: assess the utility of lower extremity compression wraps as adjuvant therapy in inpatient management of acute systolic heart failure The control group will consist of patients admitted to I5 Cardiology for management of acute systolic heart failure with intravenous diuresis and standard medical therapy, meeting inclusion criteria. Information will be gathered through observational prospective data analysis from Epic EMR, and will include daily diuretic type and dose required, daily urine output, daily creatinine, total days of admission, daily and pre-discharge weight, admission BNP, and pre-discharge BNP. The intervention group will consist of patients admitted to I5 Cardiology meeting inclusion criteria and being managed with standard medical therapy. This group will receive additional therapy using bilateral lower extremity compression wraps applied by nursing staff per pre-set protocol, and will receive education on the use of compression wraps. Patients will be instructed to wear the compression wraps for the entirety of the time they are undergoing intravenous diuresis, with pauses in care as needed for hygiene and symptom relief purposes. During the time of compression wrap application, the following data will be collected: urine output, daily weights, daily creatinine, daily and total dose and type of intravenous diuretic used. Prior to discharge, a BNP will be obtained. Endpoints (including percentage of weight reduction, total urine output achieved with diuresis, total dose requirement and type of intravenous diuresis, total days of intravenous diuresis, days to discharge, discharge BNP, and percent reduction from admission BNP) will then be compared to assess the utility of adding lower extremity compression wraps to inpatient management of acute systolic heart failure.


Clinical Trial Description

There will be two populations in this study: control group, and intervention group. 120 patients will be enrolled, 60 to group, randomized in 1:1 fashion. The control group will consist of patients admitted to I5 Cardiology for management of acute systolic heart failure with intravenous diuresis and standard medical therapy, meeting inclusion criteria. Information will be gathered through observational prospective data analysis from Epic EMR, and will include daily diuretic type and dose required, daily urine output, daily creatinine, total days of admission, daily and pre-discharge weight, admission BNP, and pre-discharge BNP. The intervention group will consist of patients admitted to I5 Cardiology meeting inclusion criteria and being managed with standard medical therapy. This group will receive additional therapy using bilateral lower extremity compression wraps applied by nursing staff per pre-set protocol, and will receive education on the use of compression wraps. Patients will be instructed to wear the compression wraps for the entirety of the time they are undergoing intravenous diuresis, with pauses in care as needed for hygiene and symptom relief purposes. During the time of compression wrap application, the following data will be collected: urine output, daily weights, daily creatinine, daily and total dose and type of intravenous diuretic used. Prior to discharge, a BNP will be obtained. Endpoints (including percentage of weight reduction, total urine output achieved with diuresis, total dose requirement and type of intravenous diuresis, total days of intravenous diuresis, days to discharge, discharge BNP, and percent reduction from admission BNP) will then be compared to assess the utility of adding lower extremity compression wraps to inpatient management of acute systolic heart failure. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04095416
Study type Interventional
Source Henry Ford Health System
Contact
Status Terminated
Phase N/A
Start date August 15, 2019
Completion date January 21, 2021

See also
  Status Clinical Trial Phase
Completed NCT03288701 - Smart SCALEs With Bioimpedance Analysis for Treatment Guidance in Decompensated Heart Failure N/A
Active, not recruiting NCT04618601 - Diuretic and Natriuretic Effect of High-dose Spironolactone in Patients With Acute Heart Failure Phase 4
Enrolling by invitation NCT06036914 - A Study of Ultra High Dose Diuretics to Treat Heart Failure Phase 2
Completed NCT03387813 - Hemodynamic-GUIDEd Management of Heart Failure N/A
Completed NCT03203629 - Heart Sounds Registry
Completed NCT04281849 - Balance, Aerobic Capacity, Mobility and Strength in Patients Hospitalized for Heart Failure (BAMS-HF) Program N/A
Not yet recruiting NCT04403659 - Telemonitoring of Patients Admitted in Hospital at Home With Acute Decompensated Heart Failure - Pilot Study N/A
Completed NCT03657459 - Danger Signs in Heart Failure- Effects of Video Education N/A
Completed NCT03722069 - Dietary Sodium Intake in Acute Heart Failure N/A
Completed NCT03804827 - Sleep Disordered Breathing in Acute Congestive Heart Failure
Completed NCT06468007 - Comparative Effects of Methylprednisolone and Prednisolone on the Risk of Acute Decompensated Heart Failure - An Emulated Target Trial
Completed NCT04145635 - The Aortix CRS Pilot Study N/A
Recruiting NCT04611594 - Fluid Restriction in Patients With Heart Failure N/A
Terminated NCT04643184 - Follow-up Strategies for Fragile Patients With Decompensated Heart Failure N/A
Completed NCT03200860 - Effects of Empagliflozin on Clinical Outcomes in Patients With Acute Decompensated Heart Failure Phase 2
Terminated NCT05751772 - Improving Knowledge in Heart Failure Inpatient With Therapeutic Education N/A
Recruiting NCT03586336 - Remote Dielectric Sensing (ReDS) Assisted Diuresis in Acute Decompensated Heart Failure N/A
Recruiting NCT03103932 - Biomarker Guided Discharge of Heart Failure Patients N/A
Recruiting NCT05498584 - Targeting LOXL2 and Cardiac Fibrosis for Post-acute Heart Failure Treatment- A Prospective Study
Recruiting NCT05677100 - Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure N/A